Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Granulocyte Colony-Stimulating Factor × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 8 Leukemia, Biphenotypic, Acute 6 Burkitt Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Hodgkin Disease 4 Recurrence 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Hematologic Neoplasms 3 Breast Neoplasms 3 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Anemia, Refractory, with Excess of Blasts 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Primary Myelofibrosis 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡